Moonlake Immunotherapeutics (MLTX)

Is Moonlake Immunotherapeutics (MLTX) A Buy Now?

According to our latest analysis, MLTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 9 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on MLTX, as trading bearish markets can be challenging and may result in losses.

1. RSI (Relative Strength Index): The RSI(14) value of 47.69 indicates that MLTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
2. STOCH (Stochastic Oscillator): The STOCH value of 62.11 indicates that MLTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 69.78 indicates that MLTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
4. ADX (Average Directional Index): The ADX value of 34.23 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
5. CCI (Commodity Channel Index): A CCI(14) value of 23.56 indicates that MLTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term MLTX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Moonlake Immunotherapeutics financial reports and earnings history, Moonlake Immunotherapeutics (MLTX) stock could reach $72.77 by 2030, $92.82 by 2040 and $112.86 by 2050. See the projected annual prices until 2050 of the Moonlake Immunotherapeutics stock below:

• Moonlake Immunotherapeutics (MLTX) is expected to reach an average price of $39.27 in 2035, with a high prediction of $82.79 and a low estimate of $26.04. This indicates an +242.41% change from the last recorded price of $11.47.
• Moonlake Immunotherapeutics (MLTX) stock is projected to chart a bullish course in 2040, with an average price target of $44.23, representing an +285.58% change from its current level. The forecast ranges from a conservative $36.08 to a sky-high $92.82.
• Our analysts predict Moonlake Immunotherapeutics (MLTX) to change +387.57% by 2045, soaring from $46.13 to an average price of $55.92, potentially reaching $102.84. While $46.13 is the low estimate, the potential upside is significant.
• Moonlake Immunotherapeutics (MLTX) stock is expected to climb by 2050, reaching an average of $64.93, a +466.08% change from its current level. However, a wide range of estimates exists, with high and low targets of $112.86 and $56.17, respectively, highlighting the market's uncertainty.

Moonlake Immunotherapeutics Stock (MLTX) Year by Year Forecast